Background: Although disease-modifying anti-rheumatic drugs (DMARDs) are the cornerstone of treatment for inflammatory rheumatic diseases, medication adherence to DMARDs is often suboptimal. Effective interventions to improve adherence to DMARDs are lacking, and new targets are needed to improve adherence. The aim of the present study was to explore patients' barriers and facilitators of optimal DMARD use. These factors might be used as targets for adherence interventions. Methods: In a mixed method study design, patients (n = 120) with inflammatory arthritis (IA) completed a questionnaire based on an existing adapted Theoretical Domains Framework (TDF) to identify facilitators and barriers of DMARD use. A subgroup of these patients (n = 21...
Introduction: Non-adherence to disease-modifying antirheumatic drugs (DMARDs) hampers the targets of...
Rheumatoid Arthritis (RA) is an autoimmune inflammatory joint disease of unknown etiology that affec...
Objectives To explore what considerations patients have when deciding about disease-modifying anti-r...
Background: Although disease-modifying anti-rheumatic drugs (DMARDs) are the cornerstone of treatmen...
Background: Although disease-modifying anti-rheumatic drugs (DMARDs) are the cornerstone of treatmen...
Background Disease-modifying anti-rheumatic drugs (DMARDs) are the cornerstone of rheumatoid arthrit...
IntroductionFacilitators and barriers of adherence to disease-modifying anti-rheumatic drugs (DMARDs...
Introduction Facilitators and barriers of adherence to disease-modifying anti-rheumatic drugs (DMARD...
Sharan K Rai,1 Alyssa Howren,1,2 Elizabeth S Wilcox,3 Anne F Townsend,1,4 Carlo A Marra,1,5 J Antoni...
Objectives Treatment non-adherence is more frequent among difficult-to-treat (D2T) than among non-D2...
OBJECTIVE:Adherence to medications among patients with rheumatic diseases is often suboptimal. Patie...
Contains fulltext : 79858.pdf (publisher's version ) (Closed access)OBJECTIVE: Non...
<div><p>Objective</p><p>Adherence to medications among patients with rheumatic diseases is often sub...
Introduction: Non-adherence to disease-modifying antirheumatic drugs (DMARDs) hampers the targets of...
Rheumatoid Arthritis (RA) is an autoimmune inflammatory joint disease of unknown etiology that affec...
Objectives To explore what considerations patients have when deciding about disease-modifying anti-r...
Background: Although disease-modifying anti-rheumatic drugs (DMARDs) are the cornerstone of treatmen...
Background: Although disease-modifying anti-rheumatic drugs (DMARDs) are the cornerstone of treatmen...
Background Disease-modifying anti-rheumatic drugs (DMARDs) are the cornerstone of rheumatoid arthrit...
IntroductionFacilitators and barriers of adherence to disease-modifying anti-rheumatic drugs (DMARDs...
Introduction Facilitators and barriers of adherence to disease-modifying anti-rheumatic drugs (DMARD...
Sharan K Rai,1 Alyssa Howren,1,2 Elizabeth S Wilcox,3 Anne F Townsend,1,4 Carlo A Marra,1,5 J Antoni...
Objectives Treatment non-adherence is more frequent among difficult-to-treat (D2T) than among non-D2...
OBJECTIVE:Adherence to medications among patients with rheumatic diseases is often suboptimal. Patie...
Contains fulltext : 79858.pdf (publisher's version ) (Closed access)OBJECTIVE: Non...
<div><p>Objective</p><p>Adherence to medications among patients with rheumatic diseases is often sub...
Introduction: Non-adherence to disease-modifying antirheumatic drugs (DMARDs) hampers the targets of...
Rheumatoid Arthritis (RA) is an autoimmune inflammatory joint disease of unknown etiology that affec...
Objectives To explore what considerations patients have when deciding about disease-modifying anti-r...